Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Breast Neoplasms 13cyclopia sequence 7Neoplasms 5Polycystic Ovary Syndrome 4Prostatic Neoplasms 3Multiple Myeloma 3Lung Neoplasms 3Leiomyoma 3Head and Neck Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Vomiting 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain 2Obesity 2Neoplasms, Plasma Cell 2Nausea 2Hematologic Diseases 2Fatigue 2Depression 2Weight Loss 1Warts 1Urinary Bladder Neoplasms 1Testicular Neoplasms 1Sleepiness 1Sezary Syndrome 1Prostatic Intraepithelial Neoplasia 1Primary Myelofibrosis 1Peripheral Nervous System Diseases 1Pediatric Crohn's disease 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1

Interventions

Prednisone 112Docetaxel 87Leuprolide 79enzalutamide 72Abiraterone Acetate 67bicalutamide 53Goserelin 50acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 42Radiotherapy 39abiraterone 28Magnetic Resonance Spectroscopy 27Gonadotropin-Releasing Hormone 24gallium 68 PSMA-11 23apalutamide 22Androgen Antagonists 22luprolide acetate gel depot 21sipuleucel-T 20Radiosurgery 20Triptorelin Pamoate 18cabazitaxel 17cabozantinib 16Radiotherapy, Intensity-Modulated 16Flutamide 16pembrolizumab 15radium Ra 223 dichloride 14Prednisolone 14Nivolumab 14Dutasteride 14Dexamethasone 14Radiation 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Prostatic Neoplasms × Sugars × Clear all
NCT00354432 2021-09-28

Soy Protein/Effexor Hormone Therapy for Prostate Cancer

Wake Forest University Health Sciences

Phase 3 Terminated
120 enrolled 11 charts
Genitourinary

Prostatic Neoplasms, Hot Flashes

NCT01443026 2019-11-19

The Effects of Lycopene on High Risk Prostatic Tissue

University of Illinois at Chicago

Phase 2 Completed
66 enrolled 8 charts
Genitourinary

Prostatic Neoplasms, Prostatic Intraepithelial Neoplasia, Male Urogenital Diseases

NCT00004635 2018-05-22

Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer

National Institutes of Health Clinical Center (CC)

Phase 3 Completed
159 enrolled 9 charts
Genitourinary

Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡